Generation of a monoclonal antibody that inhibits the procoagulant activity of various cancer cell lines

Cancer

Volumn 82, Issue 8, 1998, Pages 1563-1569

  Inufusa, Haruhiko ^a   Adachi, Toshiyuki ^a   Suzuki, Motoyuki ^b   Ando, Osamu ^b   Ohta, Tsunetaka ^b   Kurimoto, Masashi ^b   Nakatani, Yoshihiro ^a   Nakamura, Masato ^a   Yasutomi, Masayuki ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b HAYASHIBARA BIOCHEMICAL LABORATORIES INC   (Japan)

Author keywords

Cancer cell lines; Cancer cell derived blood coagulating activity 1 (CCA 1); Tissue factor; Tumor procoagulant

Indexed keywords

BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 9; CANCER CELL DERIVED BLOOD COAGULATING ACTIVITY 1; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY FS 01; PROCOAGULANT; THROMBOPLASTIN; TUMOR PROCOAGULANT; UNCLASSIFIED DRUG;

ARTICLE; BLOOD CLOTTING; CANCER CELL CULTURE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ADULT; ANIMALS; ANTIBODIES, MONOCLONAL; BLOOD COAGULATION FACTOR INHIBITORS; BLOOD COAGULATION FACTORS; BLOOD COAGULATION TESTS; CARCINOMA, SQUAMOUS CELL; CYSTEINE ENDOPEPTIDASES; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; FLOW CYTOMETRY; HUMANS; MICE; MICE, INBRED BALB C; NEOPLASM PROTEINS; NEUTRALIZATION TESTS; TUMOR CELLS, CULTURED; UTERINE NEOPLASMS;

EID: 0032522967     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19980415)82:8<1563::AID-CNCR19>3.0.CO;2-2     Document Type: Article

References (23)

1. Zacharski LR, Wojtukiewicz MZ, Costantini V, Ornstein DL, Memoli VA. Pathways of coagulation/fibrinolysis activation in malignancy. Semin Thromb Hemost 1992;18:104-16.
2. Dvorak HF, Van DeWater L, Bitzer AM, Anderson D, Harvey VS, Bach R, et al. Procoagulant activity associated with plasma membrane vesicles shed by cultured tumor cells. Cancer Res 1983;43:4434-42.
3. Zacharski LR, Memoli AA, Rousseau SM. Thrombin specific sites of fibrinogen in small cell carcinoma of the lung. Cancer 1988;62:299-302.
4. Vijaya Mohan Rao L. Tissue factor as a tumor procoagulant. Cancer Metastasis Rev 1992;11:249-66.
5. Bromberg ME, Konigsberg WH, Madison JF, Oawashe A, Garen A. Tissue factor promotes melanoma metastasis by a pathway independent of blood coagulation. Proc Natl Acad Sci U S A 1995;92:8205-9.
6. Bach R. Initiation of coagulation by tissue factor. CRC Crit Rev Biochem 1988;23:339-68.
7. Maynard J, Heckaman C, Pitlick F, Nemerson Y. Association of tissue factor activity with the surface of cultured cells. J Clin Invest 1975;55:814-24.
8. Walsh J, Geczy C. Discordant expression of tissue factor antigen and procoagulant activity of human monocytes. Thromb Haemost 1991;66:552-8.
9. Greeno EW, Bach RR, Moldow CF. Apotosis is associated with increased cell surface tissue factor procoagulant activity. Lab Invest 1996;75:281-9.
10. Gordon SG, Franks JJ, Lewis B. Cancer procoagulant A: a factor X activating procoagulant from malignant tissue. Thromb Res 1975;6:127-37.
11. Gordon SG, Chelladurai M. Non-tissue factor procoagulants in cancer cells. Cancer Metastasis Rev 1992;11:267-82.
12. Falanga A, Gordon SG. Comparison of properties of cancer procoagulant and human amnion-chorion procoagulant. Biochem Biophys Acta 1985;831:161-5.
13. Falanga A, Alessio MG, Donati MB, Barbui T. A new procoagulant in acute leukemia. Blood 1988;71:870-5.
14. Gordon SG, Cross BA. An enzyme-linked immunosorbent assay for cancer procoagulant and its potential as a new tumor marker. Cancer Res 1990;50:6229-34.
15. Kozwich DL, Kramer LC, Mielicki WP, Fotopoulos SS, Gordon SG. Application of cancer procoagulant as an early detection tumor marker. Cancer 1994;74:1367-76.
16. Francis JL, EL-Baruni K, Roath OS, Taylor I. Factor X-activating activity in normal and malignant colorectal tissue. Thromb Res 1988;52:207-17.
17. Inufusa H, Hara S, Mori N, Yasutomi M. Establishment and characterization of a human squamous cell carcinoma cell line LK-52 which produces a direct activator of coagulation factor X. Hum Cell 1992;5:287-91.
18. Gordon SG, Mourad AM. The site of activation of factor X by cancer procoagulant. Blood Coagul Fibrinolysis 1991;2:735-9.
19. Kshler G, Milstein C. Derivation of specific antibody-producing tissue culture and tumor lines by cell fusion. Eur J Immunol 1976;6: 511-6.
20. Chelladurai M, Honn KV, Walz DA. HLA-DR is a procoagulant. Biochem Biophys Res Commun 1991;178:467-73.
21. Pineo GF, Regoeczi E, Hatton MW. The activation of coagulation by extracts of mucus: a possible pathway of intravascular coagulation accompanying adenocarcinomas. J Lab Clin Med 1973;82:255-66.
22. Pangasnan RS, Devereux D, DeCunzo L, Karp G. The production of a factor X activator by a methylcholanthrene-induced rat fibrosarcoma. Thromb Haemost 1992;68:407-12.
23. Adamson AS, Luckert P, Pollard M, Snell ME, Amirkhosravi M, Francis JL. Procoagulant activity may be a marker of the malignant phenorype in experimental prostate cancer. Br J Cancer 1994;69:286-91.